BCAL Diagnostics Limited (ASX:BDX)

BCAL Diagnostics Revenue

In the fiscal year ending June 30, 2026, BCAL Diagnostics had annual revenue of 2.35M AUD, down -11.25%. BCAL Diagnostics had revenue of 1.08M in the half year ending June 30, 2026, a decrease of -8.89%.

• Revenue: 2.35M
• Revenue Growth: -11.25%
• P/S Ratio: 10.97
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 25.81M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	2.35M	-298.11K	-11.25%
Jun 30, 2025	2.65M	-396.37K	-13.01%
Jun 30, 2024	3.05M	256.17K	9.18%
Jun 30, 2023	2.79M	2.07M	288.29%
Jun 30, 2022	718.67K	443.42K	161.09%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 16, 2026

Data Sources Report a data error